At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ZLAB Zai Lab Ltd
Closed Good Friday 04-17 16:00:00 EDT
28.84
-0.09
-0.33%
盘后28.84
+0.000.00%
19:49 EDT
| High29.22 | Low28.34 | Vol778.49K |
| Open28.93 | D1 Closing28.94 | Amplitude3.04% |
| Mkt Cap3.16B | Tradable Cap2.89B | Total Shares109.64M |
| T/O22.43M | T/O Rate0.78% | Tradable Shares100.18M |
| P/B-- | ROE-- | EPS0.00 |
| 52wk High-- | 52wk Low-- | P/E-- |
| Dividend-- | Div.Yield-- | ROA-- |
Loading ...
All You Need to Know About Zai Lab Limited (ZLAB) Rating Upgrade to Buy
Zacks · 04-15
Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last?
Zacks · 04-14
Press Release: Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025
Dow Jones · 04-14
Zai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff Rollout
Insider Monkey · 04-10
Zai Lab (ZLAB) Gets a Buy from Scotiabank
TIPRANKS · 04-07
Asian Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
MT Newswires Live · 04-01
Spotlight On High Growth Tech Stocks In The US March 2025
Simply Wall St. · 03-31
Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
MT Newswires Live · 03-27
Institutional investors in Zai Lab Limited (NASDAQ:ZLAB) see US$441m decrease in market cap last week, although long-term gains have benefitted them.
Simply Wall St. · 03-27
Institutional investors in Zai Lab Limited (NASDAQ:ZLAB) see US$441m decrease in market cap last week, although long-term gains have benefitted them.
Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
MT Newswires Live · 03-26
Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting
Business Wire · 03-26
Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025?
Insider Monkey · 03-14
Zai Lab announces acceptance of BLA for TIVDAK in cervical cancer
TipRanks · 03-14
Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Perspective Therapeutics (CATX) and Edesa Biotech (EDSA)
TIPRANKS · 03-13
JPMorgan Adjusts Price Target on Zai Lab to $51 From $44, Keeps Overweight Rating
MT Newswires Live · 03-13
Zai Lab's Tivdak Marketing Application Accepted in China for Cervical Cancer Treatment
MT Newswires Live · 03-13
Zai Lab (ZLAB) Initiated with a Buy at Scotiabank
TIPRANKS · 03-10
Zai Lab Initiated at Sector Outperform by Scotiabank
Dow Jones · 03-07
Zai Lab initiated with an Outperform at Scotiabank
TIPRANKS · 03-07
Zai Lab Limited's (NASDAQ:ZLAB) 31% Share Price Surge Not Quite Adding Up
Simply Wall St. · 03-06
Zai Lab Limited's (NASDAQ:ZLAB) 31% Share Price Surge Not Quite Adding Up
Introduction
Company Name.
Zai Lab Ltd
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
Issue price:
--
Invest in Global Markets with Tiger Brokers!Open App